Atrial fibrillation trials recruiting in Connecticut

All Atrial fibrillation trials nationally

Cities in Connecticut

Recruiting trials in Connecticut

• A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
  NCT06455098 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Connecticut: Hartford
• Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
  NCT04045665 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Danbury, New Haven
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
  NCT03907046 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Danbury, Hartford, New Haven
• Medtronic Terminate AF Study
  NCT03546374 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Hartford
• Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
  NCT06957366 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Hartford
• STOP AF First Post-Approval Study
  NCT05227053 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Stamford
• Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
  NCT05712200 · Phase: Phase 3 · Ages: 65 Years and older · Sex: All (male and female) · Connecticut: Stamford